Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Int J Biol Sci 2023; 19(2):675-690. doi:10.7150/ijbs.79125 This issue Cite

Research Paper

Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain

Kaige Ma1,2, Gurjit Singh1, Jun Wang1, InSug O-Sullivan1, Gina Votta-Velis3, Benjamin Bruce4, Arivarasu Natarajan Anbazhagan5, Andre J. van Wijnen1,6✉, Hee-Jeong Im1,4✉

1. Department of Biomedical Engineering, the University of Illinois at Chicago, Chicago, IL, USA.
2. Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3. Department of Anesthesiology, the University of Illinois at Chicago, Chicago, IL, USA.
4. Jesse Brown Veterans Affairs Medical Center (JBVAMC) at Chicago, IL 60612, USA.
5. Department of Medicine, the University of Illinois at Chicago, Chicago, IL, USA.
6. Department of Biochemistry, University of Vermont, Burlington, VT 05405, USA.

✉ Corresponding authors: Hee-Jeong Im, Department of Biomedical Engineering, University of Illinois at Chicago, 851 S. Morgan St, Chicago, IL, USA. E-mail: hsampe2edu; Dr. Andre J. van Wijnen, Department of Biochemistry, University of Vermont, Bu More

Citation:
Ma K, Singh G, Wang J, O-Sullivan I, Votta-Velis G, Bruce B, Anbazhagan AN, van Wijnen AJ, Im HJ. Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain. Int J Biol Sci 2023; 19(2):675-690. doi:10.7150/ijbs.79125. https://www.ijbs.com/v19p0675.htm
Other styles

File import instruction

Abstract

Graphic abstract

Pain is the major reason that patients suffering from osteoarthritis (OA) seek medical care. We found that vascular endothelial growth factors (VEGFs) mediate signaling in OA pain pathways. To determine the specific contributions of VEGFs and their receptors (VEGFRs) to joint pathology and pain transmission during OA progression, we studied intra-articular (IA) injections of VEGF ligands into murine knee joints. Only VEGF ligands specific for the activation of VEGFR1, but not VEGFR2, induced allodynia within 30 min. Interventions in OA by inhibitors of VEGFRs were done in vivo using a preclinical murine OA model by IA injections of selective inhibitors of VEGFR1/VEGFR2 kinase (pazopanib) or VEGFR2 kinase (vandetanib). OA phenotypes were evaluated using pain-associated murine behavioral tests and histopathologic analyses. Alterations in VEGF/VEGFR signaling by drugs were determined in knee joints, dorsal root ganglia, and spinal cord by immunofluorescence microscopy. Pazopanib immediately relieved OA pain by interfering with pain transmission pathways. Pain reduction by vandetanib was mainly due to the inhibition of cartilage degeneration by suppressing VEGFR2 expression. In conclusion, IA administration of pazopanib, which simultaneously inhibits VEGFR1 and VEGFR2, can be developed as an ideal OA disease-modifying drug that rapidly reduces joint pain and simultaneously inhibits cartilage degeneration.

Keywords: Osteoarthritis, cartilage degeneration, joint pain, VEGFRs, pazopanib

Citation styles

APA
Ma, K., Singh, G., Wang, J., O-Sullivan, I., Votta-Velis, G., Bruce, B., Anbazhagan, A.N., van Wijnen, A.J., Im, H.J. (2023). Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain. International Journal of Biological Sciences, 19(2), 675-690. https://doi.org/10.7150/ijbs.79125.

ACS
Ma, K.; Singh, G.; Wang, J.; O-Sullivan, I.; Votta-Velis, G.; Bruce, B.; Anbazhagan, A.N.; van Wijnen, A.J.; Im, H.J. Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain. Int. J. Biol. Sci. 2023, 19 (2), 675-690. DOI: 10.7150/ijbs.79125.

NLM
Ma K, Singh G, Wang J, O-Sullivan I, Votta-Velis G, Bruce B, Anbazhagan AN, van Wijnen AJ, Im HJ. Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain. Int J Biol Sci 2023; 19(2):675-690. doi:10.7150/ijbs.79125. https://www.ijbs.com/v19p0675.htm

CSE
Ma K, Singh G, Wang J, O-Sullivan I, Votta-Velis G, Bruce B, Anbazhagan AN, van Wijnen AJ, Im HJ. 2023. Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain. Int J Biol Sci. 19(2):675-690.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use